Cargo proteins moving along the secretory pathway are sorted at the TGN (trans-Golgi network) into distinct carriers for delivery to the plasma membrane or endosomes. Recent studies in yeast and mammals have shown that formation of these carriers is regulated by PtdIns(4)P. This phosphoinositide is abundant at the TGN and acts to recruit components required for carrier formation to the membrane. Other phosphoinositides are also present on the TGN, but the extent to which they regulate trafficking is less clear. Further characterization of phosphoinositide kinases and phosphatases together with identification of new TGN-associated phosphoinositide-binding proteins will reveal the extent to which different phosphoinositides regulate TGN trafficking, and help define the molecular mechanisms involved.
Introduction
The TGN (trans-Golgi network) is the final compartment encountered by cargo proteins as they transit the Golgi apparatus [1, 2] . A major function of the TGN is to segregate cargo into distinct carriers for delivery to different destinations. Proteins are constitutively delivered to the plasma membrane in pleiomorphic tubulosaccular structures that extend from the TGN and pinch off before motor-driven translocation to the cell surface, where they undergo fusion. In polarized cells, distinct tubulosaccular carriers mediate delivery of proteins to the apical and basolateral membranes respectively. Proteins destined for delivery to the endosome/lysosome system are instead packaged into TGN-derived clathrin-coated intermediates that translocate to the peripheral cytoplasm where they fuse with endosomes. In regulated secretory cells, a fourth pathway exists in which cargo is packaged into secretory granules that fuse with the plasma membrane upon stimulation. There is accumulating evidence that formation of these different TGN carriers is regulated by phosphoinositides. These lipids exist in multiple forms that are phosphorylated at different positions within the inositol headgroup. Different phosphoinositide species are specifically recognized by modular binding domains in proteins to facilitate their recruitment and sometimes activation at the appropriate membrane [3] . In this way, phosphoinositides can regulate membrane identity and function. In this review, we will discuss the role of phosphoinositides in regulating trafficking from the TGN, with particular emphasis on PtdIns(4)P, which regulates traffic to both the plasma membrane and endosomes (see Figure 1 ).
PtdIns(4)P and trafficking from the TGN to the plasma membrane
The first indication that phosphoinositides could regulate trafficking at the TGN came from analysis of the PITP (phosphatidylinositol-transfer protein) Sec14 in yeast [4] . The ability of Sec14 to deliver PtdIns to Golgi membranes was found to be critical for secretion, although the underlying mechanisms were not known. It now appears that PtdIns can influence trafficking by acting as a precursor for PtdIns(4)P. Yeast possess a single Golgi-localized PI4K (phosphoinositide 4-kinase), Pik1, and mutation of this protein reduces cellular PtdIns(4)P levels and inhibits TGN to plasma membrane traffic [5] [6] [7] . Pik1 overexpression gives the opposite results, and this can be antagonized by Sac1, a phosphatase that hydrolyses PtdIns(4)P [as well as PtdIns(3)P, PtdIns(5)P and PtdIns(3,5)P 2 ] to PtdIns [8] . Together, these findings indicate a key role for PtdIns(4)P in TGN-to-plasma-membrane transport. This is likely to be a direct effect and not due to PtdIns(4)P acting as a precursor for PtdIns(4,5)P 2 , since the only yeast PI4P5K (phosphoinositide 4-phosphate 5-kinase), Mss4, is located at the plasma membrane and Mss4 mutants have normal secretion [9] .
Mammals possess several PI4Ks. The mammalian homologue of Pik1 type-III PI4K␤ is recruited to the Golgi apparatus by the small GTPase ARF (ADP-ribosylation factor), suggesting a role in membrane traffic [10] . Overexpression of PI4K␤ inhibits transport from the TGN to both the apical and basolateral plasma membranes, whereas expression of a kinase-dead form inhibits TGN-to-basolateral delivery while stimulating TGN-to-apical-membrane transport [11] . Interestingly, it has recently been shown that PI4K␤ can recruit Rab11 to the Golgi apparatus, suggesting that it may regulate trafficking not only by modulation of PtdIns(4)P levels, but also through Rab11 recruitment [12] . In line with this, expression of a mutant PI4K␤ defective in Rab11 binding inhibits TGN-to-plasma-membrane traffic. The major PI4K at the mammalian Golgi apparatus is type-II PI4K␣ [13] . Depletion of this kinase by RNA interference significantly reduces Golgi PtdIns(4)P levels, abolishes binding of Golgi-associated PtdIns(4)P-binding proteins (see below), and inhibits TGN to cell-surface transport [13] . Another potential regulator of PtdIns(4)P synthesis at the TGN is PKD (protein kinase D). This kinase is localized to specific domains of the TGN and regulates formation of constitutive TGN to plasma membrane carriers [14] . PKD can associate with a type II PI4K and a PI4P5K, and this association is promoted by PKD activity, suggesting that PKD may regulate levels of PtdIns(4)P [and PtdIns(4,5)P 2 ] during trafficking from the TGN [15] .
How does PtdIns(4)P regulate TGN to plasma membrane traffic? Several PtdIns(4)P-binding proteins have been localized to the Golgi apparatus. FAPP (four-phosphate-adaptor protein) 1 and 2 are recruited to the TGN by a PH (pleckstrin homology) domain that interacts with both PtdIns(4)P and ARF [16] . Depletion of FAPPs inhibits delivery of cargo from the TGN to the cell surface, indicating a key role for these proteins in this transport step. Interestingly, overexpression of the FAPP PH domain appears to inhibit fission of TGN tubules, suggesting that FAPPs may regulate the formation of Formation of tubulosaccular carriers destined for the plasma membrane is regulated by FAPP1, which is recruited to the membrane via binding of its PH domain to PtdIns(4)P and membrane-associated ARF. Once on the membrane, FAPP1 is thought to regulate scission of transport carriers. Other related proteins (FAPP2, OSBP and GPBP) may regulate scission of different carriers destined for the plasma membrane. Budding of clathrin-coated vesicles from the TGN and early endosomes requires the accessory proteins AP-1 and epsinR. Both proteins are recruited to the membrane through association with PtdIns(4)P and ARF. AP-1 binds to cytoplasmic tails of cargo proteins for sorting into transport intermediates, and, together with epsinR, promotes assembly of the clathrin coat.
TGN-derived carriers. They may do this directly, perhaps acting in a manner analogous to vesicle coat proteins, or indirectly, by influencing the availability of PtdIns(4)P for other enzymes or fission-promoting proteins. OSBP (oxysterol-binding protein) and GPBP (Goodpasture antigen-binding protein) also contain PtdIns(4)P-binding PH domains and are localized to the Golgi apparatus [17, 18] . The function of these proteins is unclear, but a role in carrier formation appears likely. Together with FAPPs, they may comprise a family that regulates the formation of distinct classes of TGN-derived carriers.
PtdIns(4)P and trafficking from the TGN to endosomes
PtdIns(4)P also regulates transport from the TGN to endosomes. The first indication of this came when Pik1 mutant strains were found to have a reduced rate of delivery of proteins from the TGN to the pre-vacuolar compartment and the vacuole (the yeast equivalent of endosomes and the lysosome in animals) [6, 7] . Further evidence came from studies on the yeast synaptojanin-like protein Sjl3/Inp53, which has both Sac1-like and PtdIns(4,5)P 2 5-phosphatase domains [19, 20] . Both activities are required for proper delivery of proteins from the TGN to the pre-vacuolar compartment and vacuole, suggesting that PtdIns(4)P is involved. Sjl3/Inp53 binds to clathrin, further supporting a role for this protein in clathrin-mediated trafficking at the TGN. PtdIns(4)P effectors that regulate clathrin budding at the TGN have recently been identified. The tetrameric clathrin adaptor AP-1 (adaptor protein 1) mediates cargo selection and clathrin-coat assembly at the TGN, and is targeted to the membrane by association with both PtdIns(4)P and ARF [13] . Similarly, the AP-1 accessory protein epsinR also has a dual requirement for PtdIns(4)P and ARF for membrane binding [21] [22] [23] [24] . Thus PtdIns(4)P plays a direct role in budding of clathrin-coated vesicles from the TGN. Recent studies suggest it may perform a similar function on endosomes, since both AP-1 and epsinR have been localized to clathrin buds there, and both are required for efficient retrograde trafficking from endosomes to the TGN [25] [26] [27] [28] [29] [30] .
PtdIns(4,5)P 2 at the TGN
Labelling of yeast with a PH domain specific for PtdIns(4,5)P 2 suggests that this phosphoinositide is present at the Golgi apparatus at very low levels, consistent with the lack of a Golgi-associated PI4P5K in these cells [31] . Similarly, mammalian cells also appear to have low steady-state levels of Golgi-associated PtdIns(4,5)P 2 [32] . However, PI4P5K activity has been measured in Golgi membranes isolated from mammalian cells, and, interestingly, this activity is stimulated by ARF, suggesting a role in membrane traffic [33, 34] . A role for PtdIns(4,5)P 2 in Golgi trafficking is supported further by the finding that inhibition of TGN to cell-surface transport upon PI4KII␣ depletion is rescued by shuttling PtdIns (4,5)P 2 into the cells [13] . The mechanism by which PtdIns(4,5)P 2 regulates this step is unknown, despite a number of potential PtdIns(4,5)P 2 effectors having been identified. PtdIns(4,5)P 2 is a potent stimulator of PLD (phospholipase D), a Golgi-associated enzyme that catalyses the production of PA (phosphatidic acid) [35] . PA may promote membrane fission by physically inducing membrane curvature. Alternatively, it may be converted into DAG (diacylglycerol), which stimulates TGN-to-plasma-membrane trafficking through activation of PKD [36] . PA is also an activator of PI4P5K activity, giving rise to a potential positivefeedback loop for PtdIns(4,5)P 2 synthesis [37, 38] . This, combined with the ability of PtdIns(4,5)P 2 to regulate members of the ARF GAP (GTPase-activating protein) and GEF (guanine nucleotide-exchange factor) families and thereby regulate ARF activation [39] , might allow for a very rapid, but tightly controlled, production of PtdIns(4,5)P 2 at localized sites on the TGN. Other potential PtdIns(4,5)P 2 effectors include dynamin 2, which has been implicated in budding of TGNderived clathrin-coated vesicles, and Golgi spectrin, which may regulate ARF-mediated trafficking and/or Golgi architecture via the actin cytoskeleton [10, 40] . Further characterization of these proteins and identification of new Golgi-associated PtdIns(4,5)P 2 -binding proteins will be required to understand the role of this phosphoinositide in trafficking at the TGN.
Several phosphoinositide 5-phosphatases have been described at the mammalian Golgi apparatus, but only one has a marked preference for PtdIns(4,5)P 2 . Mutations in this protein, called OCRL1, are responsible for the rare X-linked disorder OCRL (oculocerebrorenal syndrome of Lowe), characterized by defects in the brain, kidney and eye [41, 42] . OCRL1 is present at the TGN [43, 44] , and one study also suggests a lysosomal localization [45] . Cells from OCRL patients have elevated levels of PtdIns(4,5)P 2 , suggesting that changes in phosphoinositide levels contribute to the disease state [45, 46] . One mechanism may be through alteration of the actin cytoskeleton, which is perturbed in OCRL patient cells [47] . Another possibility is that OCRL1 regulates membrane traffic at the TGN through modulation of PtdIns(4)P and/or PtdIns(4,5)P 2 levels. Alternatively, its main function may be to 'mop up' excess PtdIns(4,5)P 2 to maintain the relatively high and low levels of PtdIns(4)P and PtdIns(4,5)P 2 respectively at the TGN.
Other phosphoinositides
Phosphoinositides phosphorylated at the 3-position have not been detected at the Golgi apparatus using specific probes. This contrasts with endosomes, which are abundant in both PtdIns(3)P and PtdIns(3,5)P 2 , and contain many proteins that specifically bind to these lipids [48] [49] [50] . However, studies using the PI3K (phosphoinositide 3-kinase) inhibitor wortmannin, as well as purified PI3K, support a role for this kinase in carrier formation and/or cargo sorting at the TGN [51] [52] [53] . More recently, the wortmannin-resistant PI3K-C2␣ has been localized to TGN-derived clathrin-coated transport intermediates, and overexpression of this protein has been shown to disrupt trafficking between the TGN and endosomes [54] . Interestingly, binding to clathrin activates PI3K-C2␣, suggesting that localized PtdIns(3)P or PtdIns(3,4,5)P 3 production contributes to clathrin bud formation. A potential regulator of this process is WIPI49 (WD40 repeat protein interacting with phosphoinositides of 49 kDa), a PtdIns(3)P-binding protein localized to the TGN and endosomes [55] . WIPI49 is enriched in clathrin-coated vesicles and is required for efficient TGN to endosome trafficking. PtdIns(3,4,5)P 3 may influence trafficking by activating the ARF-GAP activity of ARAP1 (ARF-GAP, Rho-GAP, ankyrin repeat and PH domain-containing protein 1), a Golgi-associated multifunctional signalling protein, or through activation of other members of the ARF-GAP and -GEF families [56, 57] .
Conclusions and future perspectives
Different phosphoinositides are enriched in different membrane compartments. PtdIns(4)P is abundant at the Golgi apparatus, and a number of PtdIns(4)P-binding proteins have been identified there. Several of these are localized to the TGN and are important for trafficking to both the plasma membrane and endosomes. Given the abundance of PtdIns(4)P at the Golgi apparatus, it is likely that other PtdIns(4)P effectors will be discovered there, and it will be interesting to find out what these proteins do with respect to membrane traffic. The situation with PtdIns(4,5)P 2 and 3-phosphorylated phosphoinositides is less clear. These are very abundant at the plasma membrane and endosomes respectively, and have clearly defined roles at these compartments. At the Golgi apparatus, they are much less abundant and, although a number of regulators and one or two potential effector proteins have been identified, the extent to which they mediate trafficking there is unclear. Further studies are required to resolve this issue. This will require the identification of proteins that bind to these phosphoinositides with clearly defined roles in trafficking. Only then will we fully understand the diverse roles that phosphoinositides play in membrane traffic at the Golgi apparatus. 
